The Latest Headlines at American Banking and Market News
Community West Bancshares (NASDAQ:CWBC) Price Target Lowered to $22.00 at Keefe, Bruyette & Woods
Community West Bancshares (NASDAQ:CWBC – Free Report) had its price objective trimmed by Keefe, Bruyette & Woods from $23.00 to $22.00 in a research report released on Monday, Benzinga reports. The brokerage currently has... More of this article »
Cyclo Therapeutics (NASDAQ:CYTH) Now Covered by Analysts at Ascendiant Capital Markets
Ascendiant Capital Markets began coverage on shares of Cyclo Therapeutics (NASDAQ:CYTH – Free Report) in a report issued on Monday morning, Benzinga reports. The brokerage issued a buy rating and a $2.60 target price on the stock. Cyclo... More of this article »
CVB Financial (NASDAQ:CVBF) Downgraded to Market Perform at Hovde Group
Hovde Group cut shares of CVB Financial (NASDAQ:CVBF – Free Report) from an outperform rating to a market perform rating in a report issued on Monday morning, Marketbeat reports. They currently have $18.00 price objective on... More of this article »
Cognizant Technology Solutions (NASDAQ:CTSH) Given New $82.00 Price Target at Citigroup
Cognizant Technology Solutions (NASDAQ:CTSH – Free Report) had its price target decreased by Citigroup from $90.00 to $82.00 in a research report released on Monday, Benzinga reports. Citigroup currently has a buy rating on the... More of this article »
CytomX Therapeutics (NASDAQ:CTMX) Upgraded to “Neutral” at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) from an underweight rating to a neutral rating in a research note published on Monday morning, MarketBeat.com reports. CytomX Therapeutics... More of this article »
Cisco Systems (NASDAQ:CSCO) Coverage Initiated by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. began coverage on shares of Cisco Systems (NASDAQ:CSCO – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued a neutral rating and a $53.00 price target on... More of this article »
Benitec Biopharma (NASDAQ:BNTC) Given New $16.00 Price Target at JMP Securities
Benitec Biopharma (NASDAQ:BNTC – Free Report) had its price target upped by JMP Securities from $10.00 to $16.00 in a research note released on Monday, Benzinga reports. The brokerage currently has a market outperform rating... More of this article »
Cardiol Therapeutics (NASDAQ:CRDL) Receives New Coverage from Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Cardiol Therapeutics (NASDAQ:CRDL – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The brokerage issued a buy rating and a $9.00 target price on... More of this article »
Atrion (NASDAQ:ATRI) Lowered to Sell at StockNews.com
StockNews.com cut shares of Atrion (NASDAQ:ATRI – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday. Atrion Price Performance Atrion stock opened at $399.83 on Monday. The firm... More of this article »
Cadence Design Systems (NASDAQ:CDNS) Receives Neutral Rating from Rosenblatt Securities
Rosenblatt Securities reissued their neutral rating on shares of Cadence Design Systems (NASDAQ:CDNS – Free Report) in a report released on Monday morning, Benzinga reports. Rosenblatt Securities currently has a $280.00 target... More of this article »
Cipher Mining (NASDAQ:CIFR) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Cipher Mining (NASDAQ:CIFR – Free Report) in a research note published on Monday morning, Benzinga reports. Needham & Company LLC currently has a $5.00 price... More of this article »
Calumet Specialty Products Partners (NASDAQ:CLMT) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) in a report published on Monday morning, Benzinga reports. HC Wainwright currently has a $25.00 price objective... More of this article »
Chemung Financial (NASDAQ:CHMG) Price Target Lowered to $49.00 at Keefe, Bruyette & Woods
Chemung Financial (NASDAQ:CHMG – Free Report) had its price objective lowered by Keefe, Bruyette & Woods from $51.00 to $49.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a market... More of this article »